BlackRock’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $230K | Buy |
22,860
+4,674
| +26% | +$41.3K | ﹤0.01% | 4779 |
|
|
2026
Q1 | $115K | Buy |
18,186
+1,928
| +12% | +$12.3K | ﹤0.01% | 4929 |
|
|
2025
Q4 | $100K | Buy |
16,258
+24
| +0.1% | +$141 | ﹤0.01% | 4908 |
|
|
2025
Q3 | $101K | Buy |
16,234
+440
| +3% | +$2.78K | ﹤0.01% | 4824 |
|
|
2025
Q2 | $110K | Buy |
15,794
+1,664
| +12% | +$9.7K | ﹤0.01% | 4823 |
|
|
2025
Q1 | $67.7K | Sell |
14,130
-273
| -2% | -$1.4K | ﹤0.01% | 4857 |
|
|
2024
Q4 | $74.2K | Buy |
14,403
+91
| +0.6% | +$363 | ﹤0.01% | 4851 |
|
|
2024
Q3 | $52K | Buy |
14,312
+548
| +4% | +$2.13K | ﹤0.01% | 4811 |
|
|
2024
Q2 | $66.8K | Sell |
13,764
-1,091
| -7% | -$5.25K | ﹤0.01% | 4795 |
|
|
2024
Q1 | $78.7K | Sell |
14,855
-657
| -4% | -$3.38K | ﹤0.01% | 4788 |
|
|
2023
Q4 | $79K | Sell |
15,512
-918
| -6% | -$4.48K | ﹤0.01% | 4870 |
|
|
2023
Q3 | $87.7K | Sell |
16,430
-637
| -4% | -$3.23K | ﹤0.01% | 4885 |
|
|
2023
Q2 | $85.3K | Buy |
17,067
+985
| +6% | +$5.04K | ﹤0.01% | 4967 |
|
|
2023
Q1 | $82.2K | Buy |
16,082
+486
| +3% | +$3.16K | ﹤0.01% | 5003 |
|
|
2022
Q4 | $95.1K | Buy |
15,596
+324
| +2% | +$2.34K | ﹤0.01% | 5058 |
|
|
2022
Q3 | $114K | Sell |
15,272
-405
| -3% | -$3.31K | ﹤0.01% | 5141 |
|
|
2022
Q2 | $137K | Buy |
15,677
+889
| +6% | +$7.71K | ﹤0.01% | 5142 |
|
|
2022
Q1 | $143K | Sell |
14,788
-673
| -4% | -$5.81K | ﹤0.01% | 5196 |
|
|
2021
Q4 | $124K | Buy |
15,461
+668
| +5% | +$5.97K | ﹤0.01% | 5211 |
|
|
2021
Q3 | $138K | Buy |
14,793
+2,598
| +21% | +$24.6K | ﹤0.01% | 5064 |
|
|
2021
Q2 | $115K | Sell |
12,195
-7,124
| -37% | -$69.5K | ﹤0.01% | 5010 |
|
|
2021
Q1 | $187K | Buy |
19,319
+1,834
| +10% | +$17.2K | ﹤0.01% | 4755 |
|
|
2020
Q4 | $105K | Buy |
17,485
+752
| +4% | +$4.38K | ﹤0.01% | 4573 |
|
|
2020
Q3 | $91K | Sell |
16,733
-1,642
| -9% | -$9.1K | ﹤0.01% | 4532 |
|
|
2020
Q2 | $87K | Buy |
18,375
+5,544
| +43% | +$24.2K | ﹤0.01% | 4505 |
|
|
2020
Q1 | $48K | Buy |
12,831
+11,001
| +601% | +$54.2K | ﹤0.01% | 4482 |
|
|
2019
Q4 | $10K | Hold |
1,830
| – | – | ﹤0.01% | 4738 |
|
|
2019
Q3 | $10K | Hold |
1,830
| – | – | ﹤0.01% | 4721 |
|
|
2019
Q2 | $12K | Buy |
1,830
+415
| +29% | +$2.63K | ﹤0.01% | 4743 |
|
|
2019
Q1 | $9K | Hold |
1,415
| – | – | ﹤0.01% | 4691 |
|
|
2018
Q4 | $10K | Hold |
1,415
| – | – | ﹤0.01% | 4665 |
|
|
2018
Q3 | $12K | Hold |
1,415
| – | – | ﹤0.01% | 4705 |
|
|
2018
Q2 | $10K | Buy |
1,415
+679
| +92% | +$4.87K | ﹤0.01% | 4744 |
|
|
2018
Q1 | $5K | Hold |
736
| – | – | ﹤0.01% | 4724 |
|
|
2017
Q4 | $6K | Hold |
736
| – | – | ﹤0.01% | 4698 |
|
|
2017
Q3 | $5K | Hold |
736
| – | – | ﹤0.01% | 4741 |
|
|
2017
Q2 | $5K | Hold |
736
| – | – | ﹤0.01% | 4795 |
|
|
2017
Q1 | $4K | Buy |
+736
| New | +$4.23K | ﹤0.01% | 4809 |
|
Other funds holding ICCC
CAM
BL
S
MFIM
BlackRock's ICCC Position: Q2 2026 in Review
BlackRock increased its ImmuCell (ICCC) stake by 26% in Q2 2026, buying an estimated $41.3K and bringing the position to 22,860 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #4779.
BlackRock first reported a position in ICCC in Q1 2017 and has held it in 38 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.
- BlackRock held 22,860 shares of ImmuCell worth $230K as of Q2 2026.
- BlackRock bought 4,674 ImmuCell shares in Q2 2026, an estimated $41.3K.
- ImmuCell made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4779 holding.
- BlackRock first reported a position in ImmuCell in Q1 2017 and has held it in 38 quarters since.
- 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.